Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor

We have postulated that the aryl hydrocarbon receptor (AHR) drives the later, more lethal stages of some cancers when chronically activated by endogenous ligands. However, other studies have suggested that, under some circumstances, the AHR can oppose tumor aggression. Resolving this apparent contra...

Descripción completa

Detalles Bibliográficos
Autores principales: Narasimhan, Supraja, Stanford Zulick, Elizabeth, Novikov, Olga, Parks, Ashley J., Schlezinger, Jennifer J., Wang, Zhongyan, Laroche, Fabrice, Feng, Hui, Mulas, Francesca, Monti, Stefano, Sherr, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983651/
https://www.ncbi.nlm.nih.gov/pubmed/29735912
http://dx.doi.org/10.3390/ijms19051388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983651/
https://www.ncbi.nlm.nih.gov/pubmed/29735912
http://dx.doi.org/10.3390/ijms19051388

Ejemplares similares